Patents Assigned to Iris Biotechnologies, Inc.
-
Publication number: 20140177930Abstract: The present invention provides a complete artificial intelligence system for the acquisition and analysis of nucleic acid array hybridization information. The system is divided into at least one central data processing facility and one or more user facilities, linked by encrypted network connections or similar links. Each user facility may include an optical scanning system to collect hybridization signals from a nucleic acid array, an image processing system to convert the optical data into a set of hybridization parameters, a connection to a data network, and a user interface to display, manipulate, search, and analyze hybridization information. This system reads data from a gene chip or DNA microarray, or a proteomics chip, analyzes test results based on maintained parameters, evaluates patient risk for various ailments, recommends methods of treatment, presents information to medical and/or private individuals, and notifies test participants when new treatment becomes available.Type: ApplicationFiled: March 3, 2014Publication date: June 26, 2014Applicant: Iris Biotechnologies Inc.Inventors: Glenn F. Osborne, Simon S.M. Chin, Paul McDonald, Scott Schneider
-
Patent number: 8693751Abstract: The present invention provides a complete artificial intelligence system for the acquisition and analysis of nucleic acid array hybridization information. The system includes a central data processing facility and one or more user facilities, linked by encrypted connections. Each user facility may include an optical scanning system to collect hybridization signals from a nucleic acid array, an image processing system to convert the optical data into a set of hybridization parameters, a connection to a data network, and a user interface to display, manipulate, search, and analyze hybridization information. This system reads data from a nucleic acid microarray, analyzes test results, evaluates patient risk for various ailments, and recommends methods of treatment. The automated artificial intelligence system is a real time, dynamic decision making tool that can be used in conjunction with a clinical analysis system, and with the information obtained in a research and development environment.Type: GrantFiled: January 12, 2012Date of Patent: April 8, 2014Assignee: Iris BioTechnology Inc.Inventors: Glenn F. Osborne, Simon S. M. Chin, Paul McDonald, Scott Schneider
-
Patent number: 8107693Abstract: The present invention provides a complete artificial intelligence system for the acquisition and analysis of nucleic acid array hybridization information. The system includes a central data processing facility and one or more user facilities, linked by encrypted connections. Each user facility may include an optical scanning system to collect hybridization signals from a nucleic acid array, an image processing system to convert the optical data into a set of hybridization parameters, a connection to a data network, and a user interface to display, manipulate, search, and analyze hybridization information. This system reads data from a nucleic acid microarray, analyzes test results, evaluates patient risk for various ailments, and recommends methods of treatment. The automated artificial intelligence system is a real time, dynamic decision making tool that can be used in conjunction with a clinical analysis system, and with the information obtained in a research and development environment.Type: GrantFiled: April 7, 2006Date of Patent: January 31, 2012Assignee: Iris Biotechnologies, Inc.Inventors: Glenn F. Osborne, Simon S. M. Chin, Paul McDonald, Scott Schneider
-
Patent number: 7270954Abstract: This invention is related to the immobilization of peptide nucleic acids (PNAs) onto solid surfaces for use in hybridization, purification, biosensing, and other biochemical applications. Specifically, their use to increase the thermal stability, specificity, and lifetime of devices based on in situ hybridization is disclosed. A method is disclosed by which peptide nucleic acids replace oligonucleotides as probes in the detection of specific DNA and RNA sequences.Type: GrantFiled: June 30, 2000Date of Patent: September 18, 2007Assignee: Iris Biotechnologies, Inc.Inventor: Jaime E. Ramirez-Vick
-
Patent number: 7108971Abstract: This invention is related to methods for the immobilization of labeled ligands on solid surfaces using soft metal-soft base bonding. The ligand-binding solid surface comprises a soft metal solid support and a heterobifunctional spacer chemi- or physisorbed to said soft metal solid support via soft metal-soft base bonding.Type: GrantFiled: December 19, 2001Date of Patent: September 19, 2006Assignee: Iris Biotechnologies, Inc.Inventor: Jaime E. Ramirez-Vick
-
Patent number: 7062076Abstract: The present invention provides a complete artificial intelligence system for the acquisition and analysis of nucleic acid array hybridization information. The system is divided into at least one central data processing facility and one or more user facilities, linked by encrypted network connections or similar links. Each user facility may include an optical scanning system to collect hybridization signals from a nucleic acid array, an image processing system to convert the optical data into a set of hybridization parameters, a connection to a data network, and a user interface to display, manipulate, search, and analyze hybridization information. This system reads data from a gene chip or DNA microarray, or a proteomics chip, analyzes test results based on maintained parameters, evaluates patient risk for various ailments, recommends methods of treatment, presents information to medical and/or private individuals, and notifies test participants when new treatment becomes available.Type: GrantFiled: August 28, 2000Date of Patent: June 13, 2006Assignee: Iris Biotechnologies, Inc.Inventors: Glenn F. Osborne, Simon S. M. Chin, Paul McDonald, Scott Schneider
-
Patent number: 6852493Abstract: The invention provides a method for increasing the hybridization rate of nucleic acids in a nucleic acid assay by labeling nucleic acid molecules with paramagnetic labels and activating a magnetic field inducing rapid migration of the labeled molecules to a solid support, where the labeled molecule hybridizes with its complementary pair. The paramagnetic label may be present on the target nucleic acid or the probe nucleic acid, depending upon whether the target or probe are the immobile phase.Type: GrantFiled: November 19, 2001Date of Patent: February 8, 2005Assignee: Iris Biotechnologies, Inc.Inventors: Jaime E. Ramirez-Vick, Simon Chin